SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-033933
Filing Date
2020-07-28
Accepted
2020-07-28 17:06:42
Documents
42
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20200630.htm   iXBRL 10-Q 1173613
2 EX-31.1 mnov-ex311_7.htm EX-31.1 11224
3 EX-31.2 mnov-ex312_6.htm EX-31.2 11239
4 EX-32.1 mnov-ex321_9.htm EX-32.1 7895
5 EX-32.2 mnov-ex322_8.htm EX-32.2 8002
  Complete submission text file 0001564590-20-033933.txt   3396344

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnov-20200630.xsd EX-101.SCH 24398
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20200630_cal.xml EX-101.CAL 22237
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20200630_def.xml EX-101.DEF 69878
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20200630_lab.xml EX-101.LAB 213915
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20200630_pre.xml EX-101.PRE 157491
11 EXTRACTED XBRL INSTANCE DOCUMENT mnov-10q_20200630_htm.xml XML 409672
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 201054640
SIC: 2834 Pharmaceutical Preparations